These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33115683)

  • 1. The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada-A mathematical modeling study of surveillance data.
    Godin A; Xia Y; Buckeridge DL; Mishra S; Douwes-Schultz D; Shen Y; Lavigne M; Drolet M; Schmidt AM; Brisson M; Maheu-Giroux M
    Int J Infect Dis; 2021 Jan; 102():254-259. PubMed ID: 33115683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small number of early introductions seeded widespread transmission of SARS-CoV-2 in Québec, Canada.
    Murall CL; Fournier E; Galvez JH; N'Guessan A; Reiling SJ; Quirion PO; Naderi S; Roy AM; Chen SH; Stretenowich P; Bourgey M; Bujold D; Gregoire R; Lepage P; St-Cyr J; Willet P; Dion R; Charest H; Lathrop M; Roger M; Bourque G; Ragoussis J; Shapiro BJ; Moreira S
    Genome Med; 2021 Oct; 13(1):169. PubMed ID: 34706766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Surveillance System in Canada: Longitudinal Trend Analysis.
    Post L; Boctor MJ; Issa TZ; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh L; White J; Welch SB; Oehmke JF
    JMIR Public Health Surveill; 2021 May; 7(5):e25753. PubMed ID: 33852410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A methodology for estimating SARS-CoV-2 importation risk by air travel into Canada between July and November 2021.
    Milwid RM; Gabriele-Rivet V; Ogden NH; Turgeon P; Fazil A; London D; de Montigny S; Rees EE
    BMC Public Health; 2024 Apr; 24(1):1088. PubMed ID: 38641571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
    Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the impacts of non-pharmaceutical interventions on the transmission dynamics of COVID-19 in Canada based on mobile network.
    Xue L; Jing S; Wang H
    PLoS One; 2021; 16(12):e0261424. PubMed ID: 34965272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cross-border-associated cases on the SARS-CoV-2 epidemic in Switzerland during summer 2020 and 2021.
    Reichmuth ML; Hodcroft EB; Riou J; Neher RA; Hens N; Althaus CL
    Epidemics; 2022 Dec; 41():100654. PubMed ID: 36444785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Epidemiology of SARS-CoV-2 in Greece Reveals Low Rates of Onward Virus Transmission after Lifting of Travel Restrictions Based on Risk Assessment during Summer 2020.
    Kostaki EG; Pavlopoulos GA; Verrou KM; Ampatziadis-Michailidis G; Harokopos V; Hatzis P; Moulos P; Siafakas N; Pournaras S; Hadjichristodoulou C; Chatzopoulou F; Chatzidimitriou D; Panagopoulos P; Lourida P; Argyraki A; Lytras T; Sapounas S; Gerolymatos G; Panagiotakopoulos G; Prezerakos P; Tsiodras S; Sypsa V; Hatzakis A; Anastassopoulou C; Spanakis N; Tsakris A; Dimopoulos MA; Kotanidou A; Sfikakis P; Kollias G; Magiorkinis G; Paraskevis D
    mSphere; 2021 Jun; 6(3):e0018021. PubMed ID: 34190583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first laboratory-confirmed imported infections of SARS-CoV-2 in Sudan.
    Aljak ER; Eldigail M; Mahmoud I; Elhassan RM; Elduma A; Ibrahim AA; Ali Y; Weaver SC; Ahmed A
    Trans R Soc Trop Med Hyg; 2021 Jan; 115(1):103-109. PubMed ID: 33319246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, January 2020-January 2022.
    Kehoe AD; Mallhi AK; Barton CR; Martin HM; Turner CM; Hua X; Kwok KO; Chowell G; Fung IC
    Emerg Infect Dis; 2024 May; 30(5):956-967. PubMed ID: 38666622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong-January to May 2020.
    Lam HY; Lam TS; Wong CH; Lam WH; Leung CME; Au KWA; Lam CKY; Lau TWW; Chan YWD; Wong KH; Chuang SK
    Int J Infect Dis; 2020 Sep; 98():51-58. PubMed ID: 32579906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada.
    McLaughlin A; Montoya V; Miller RL; Mordecai GJ; ; Worobey M; Poon AFY; Joy JB
    Elife; 2022 Aug; 11():. PubMed ID: 35916373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canada's provincial COVID-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responses.
    Xia Y; Flores Anato JL; Colijn C; Janjua N; Irvine M; Williamson T; Varughese MB; Li M; Osgood N; Earn DJD; Sander B; Cipriano LE; Murty K; Xiu F; Godin A; Buckeridge D; Hurford A; Mishra S; Maheu-Giroux M
    Can J Public Health; 2024 Aug; 115(4):541-557. PubMed ID: 39060710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia.
    Komissarov AB; Safina KR; Garushyants SK; Fadeev AV; Sergeeva MV; Ivanova AA; Danilenko DM; Lioznov D; Shneider OV; Shvyrev N; Spirin V; Glyzin D; Shchur V; Bazykin GA
    Nat Commun; 2021 Jan; 12(1):649. PubMed ID: 33510171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of flight connectivity on the introduction and evolution of the COVID-19 outbreak in Canadian provinces and territories.
    Hincapie R; Munoz DA; Ortega N; Isfeld-Kiely HK; Shaw SY; Keynan Y; Rueda ZV
    J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36041018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and transmission characteristics of early COVID-19 cases, 20 January-19 March 2020, in Bavaria, Germany.
    Böhm S; Woudenberg T; Chen D; Marosevic DV; Böhmer MM; Hansen L; Wallinga J; Sing A; Katz K
    Epidemiol Infect; 2021 Mar; 149():e65. PubMed ID: 33650470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East.
    Tayoun AA; Loney T; Khansaheb H; Ramaswamy S; Harilal D; Deesi ZO; Varghese RM; Al Suwaidi H; Alkhajeh A; AlDabal LM; Uddin M; Hamoudi R; Halwani R; Senok A; Hamid Q; Nowotny N; Alsheikh-Ali A
    Sci Rep; 2020 Oct; 10(1):17720. PubMed ID: 33082405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.
    Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.